Jacobio Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Jacobio Pharmaceuticals Co., Ltd., explained in plain language.
-
New pill targets KRAS cancers in early human trial
Disease control Recruiting nowThis study tests an experimental drug called JAB-23E73 in people with advanced solid tumors that have a specific genetic change (KRAS mutation or amplification). The goal is to check the drug's safety, how the body processes it, and whether it can shrink tumors. About 334 partici…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New pill targets hard-to-treat cancers with rare mutation
Disease control Recruiting nowThis study tests an experimental drug called JAB-30355 in adults with advanced solid tumors that have a specific TP53 Y220C mutation. The goal is to see if the drug is safe, tolerable, and shows signs of shrinking tumors. About 144 participants will receive the drug, and research…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC